Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $40,060 - $47,437
585 Added 107.14%
1,131 $81,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $3 - $2,305
-30 Reduced 5.21%
546 $39,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $2,105 - $2,319
29 Added 5.3%
576 $44,000
Q1 2022

Aug 15, 2022

SELL
$61.48 - $73.72 $5,287 - $6,339
-86 Reduced 13.59%
547 $40,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $1,005 - $1,178
17 Added 2.76%
633 $37,000
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $133,292 - $145,155
-2,153 Reduced 77.75%
616 $41,000
Q1 2021

Jul 16, 2021

BUY
$59.34 - $66.74 $164,312 - $184,803
2,769 New
2,769 $175,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Heritage Wealth Management, LLC Portfolio

Follow Heritage Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Management, LLC with notifications on news.